Literature DB >> 12131607

Long-term evolution of disease behavior of Crohn's disease.

Jacques Cosnes1, Stéphane Cattan, Antoine Blain, Laurent Beaugerie, Franck Carbonnel, Rolland Parc, Jean-Pierre Gendre.   

Abstract

BACKGROUND: The Vienna classification of Crohn's disease (CD) distinguishes three patient subgroups according to disease behavior: stricturing, penetrating, and inflammatory. Our aim was to assess the long-term evolution of the disease behavior of CD and to determine the predictive factors and prognostic implications of this evolution.
METHODS: Occurrence and predictive factors of a stricturing and/or a penetrating complication were searched for in 2,002 patients with CD studied retrospectively. In addition, the 1995-2000 disease course was assessed prospectively in a cohort of 646 patients with disease duration >5 years, classified according to their previous disease behavior.
RESULTS: 1,199 patients (60%) developed a stricturing (n = 254) or a penetrating (n = 945) complication. Twenty-year actuarial rates of inflammatory, stricturing, and penetrating disease were 12, 18, and 70%, respectively. The initial location of lesions was the main determinant of the time and type of the complication. In the cohort study, year-by-year activity and therapeutic requirements did not show significant sustained differences between behavioral subgroups.
CONCLUSION: Most patients with CD will eventually one day develop a stricturing or a perforating complication. Initial location determines the type of the complication. Classification of patients into a behavioral group from previous history has no impact upon activity during the following years.

Entities:  

Mesh:

Year:  2002        PMID: 12131607     DOI: 10.1097/00054725-200207000-00002

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  321 in total

1.  Serial intralesional injections of infliximab in small bowel Crohn's strictures are feasible and might lower inflammation.

Authors:  Jakob Hendel; John Gásdal Karstensen; Peter Vilmann
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

2.  Treatment of Crohn's Disease of Inflammatory, Stenotic, and Fistulizing Phenotypes.

Authors:  Marla C. Dubinsky; Phillip P. Fleshner
Journal:  Curr Treat Options Gastroenterol       Date:  2003-06

Review 3.  MRI in Crohn's disease--current and future clinical applications.

Authors:  Gionata Fiorino; Cristiana Bonifacio; Alberto Malesci; Luca Balzarini; Silvio Danese
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-22       Impact factor: 46.802

4.  Predictors of aggressive inflammatory bowel disease.

Authors:  Andres J Yarur; Sebastian G Strobel; Amar R Deshpande; Maria T Abreu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

5.  The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn's disease independent of the IL23R genotype.

Authors:  Matthias Jürgens; Stephan Brand; Rüdiger P Laubender; Julia Seiderer; Jürgen Glas; Martin Wetzke; Johanna Wagner; Simone Pfennig; Cornelia Tillack; Florian Beigel; Maria Weidinger; Fabian Schnitzler; Martin E Kreis; Burkhard Göke; Peter Lohse; Karin Herrmann; Thomas Ochsenkühn
Journal:  J Gastroenterol       Date:  2010-04-29       Impact factor: 7.527

6.  Biologic Therapies for Crohn's Disease: Update from the 2009 ACG Meeting.

Authors:  David G Binion
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-01

Review 7.  Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn's disease--review of the literature.

Authors:  Andreas G Wibmer; Anton J Kroesen; Jörn Gröne; Heinz-Johannes Buhr; Joerg-Peter Ritz
Journal:  Int J Colorectal Dis       Date:  2010-07-14       Impact factor: 2.571

8.  Tailoring the treatment to the individual in Crohn's disease.

Authors:  Edouard Louis; Jacques Belaiche; Catherine Reenaers
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

9.  Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan.

Authors:  Fumiaki Ueno; Toshiyuki Matsui; Takayuki Matsumoto; Katsuyoshi Matsuoka; Mamoru Watanabe; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2012-10-23       Impact factor: 7.527

Review 10.  Surgical treatment of anorectal crohn disease.

Authors:  Robert T Lewis; Joshua I S Bleier
Journal:  Clin Colon Rectal Surg       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.